文献速递冠心病

血流储备分数与造影引导经皮冠状动脉介入治疗的患者个体数据荟萃分析

Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis.
PubMed 文献 · Eur Heart J · 2025-01-01

该个体患者数据荟萃分析纳入5项随机对照试验共2493例患者,比较血流储备分数(FFR)引导与造影引导的经皮冠状动脉介入治疗(PCI)。

要点

  • FFR引导PCI可减少1年MACE及心肌梗死风险,主要获益来自围手术期心肌梗死减少。
  • FFR组PCI血管比例及人均支架数均低于造影组,提示可减少不必要的支架植入。
  • 30天后MACE及全因死亡无显著差异,长期获益需进一步评估。

核心结论

  • 在慢性冠脉综合征及非ST段抬高型急性冠脉综合征患者中,FFR引导PCI与1年MACE及心肌梗死风险降低相关,主要由围手术期心肌梗死减少驱动,30天后MACE及死亡率无差异。

研究设计与样本

  • 个体患者数据荟萃分析,纳入5项随机对照试验,共2493例患者(造影组1241例,FFR组1252例),比较FFR引导与造影引导PCI,随访至少1年。

主要发现

  • 非围手术期心肌梗死、30天至1年MACE及次要结局两组间无显著差异。

临床怎么用

  • 对于慢性冠脉综合征中间病变或非ST段抬高型急性冠脉综合征非罪犯血管,FFR引导PCI可减少围手术期心肌梗死及不必要的支架植入。

局限性

  • 研究未报告具体局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Several randomized controlled trials (RCTs) have compared fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) with angiography-guided PCI in different clinical settings, yielding mixed results. This individual patient data meta-analysis focused on trials where FFR was used to assess intermediate coronary lesions in chronic coronary syndrome (CCS) or non-culprit vessels in non-ST-elevation acute coronary syndromes (NSTE-ACS). METHODS: Randomized controlled trials comparing FFR- vs angiography-guided PCI with a minimum follow-up of 1 year were searched. Studies lacking angiographic inclusion criteria or using FFR for culprit arteries in NSTE-ACS were excluded. Studies including patients with ST-elevation myocardial infarction (MI) or undergoing surgical revascularization could be included after censoring these two subgroups. The primary outcome was the 1-year rate of major adverse cardiac events (MACE), defined as a composite of all-cause death, MI, and repeat revascularization. The secondary outcomes were a composite of all-cause death and MI, the individual components of the primary outcome, cardiac death, spontaneous MI, and procedural MI. The present study is registered with PROSPERO (CRD42024553676). RESULTS: Five RCTs were selected, including 2493 patients: 1241 in the angiography arm and 1252 in the FFR arm. More vessels underwent PCI in the angiography group (45.1% vs 30.2%, P < .001), with more stents implanted per patient [2.0 (2.0-3.0) vs 1.5 (1.0-2.0), P < .001]. One-year MACE occurred in 14.7% of patients in the angiography group and 12.1% in the FFR group [hazard ratio (HR) .80, 95% confidence interval (CI) .64-.99; P = .046]. The risk of MI was significantly reduced in the FFR-guided group (HR .71, 95% CI .53-.96; P = .031). These outcomes were driven by a reduction in peri-procedural MI with FFR guidance, with no significant difference between groups in non-procedural MI, MACE between 30 days and 1 year, and secondary outcomes. CONCLUSIONS: Fractional flow reserve-guided PCI was associated with reduced major adverse events in patients with CCS and NSTE-ACS due mainly to fewer peri-procedural MIs, with no differences in mortality or MACE beyond 30 days.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Mangiacapra F, Paolucci L, De Bruyne B, et al. Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis. Eur Heart J. 2025. PMID: 40831380. doi:10.1093/eurheartj/ehaf504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。